Minoxidil ameliorates myelodysplastic syndrome by targeting Wnt4 while sparing normal hematopoiesis
Authors:
Open Access
- 22 December 2025
- journal article
- research article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1)
Abstract
Hematopoietic stem cells (HSCs) maintain blood production via tightly regulated differentiation. Disruptions at this level can lead to myelodysplastic syndKeywords
Funding Information
- National Natural Science Foundation of China (32370874)
- National Natural Science Foundation of China and Research Grants Council of Hong Kong (32161160326)
- Guangdong Medical Research Foundation (B2025166)
- Key R&D Program (2024YFF1206602)
This publication has 56 references indexed in Scilit:
- Targeting USP10–FAK pathway sensitizes BCR-ABL+ leukemia cells to tyrosine kinase inhibitorsCell Investigation, 2025
- An Overview of Potential Therapeutic Agents Targeting WNT/PCP Signaling2021
- Cell-Intrinsic WNT4 Promotes Hematopoietic Stem and Progenitor Cell Self-RenewalStem Cells, 2021
- Slc20a1b is essential for hematopoietic stem/progenitor cell expansion in zebrafishScience China Life Sciences, 2021
- A Rapid Method for Directed Gene Knockout for Screening in G0 ZebrafishDevelopmental Cell, 2018
- The zebrafish: A fintastic model for hematopoietic development and diseaseWIREs Developmental Biology, 2018
- Androgenetic Alopecia: An Evidence-Based Treatment UpdateAmerican Journal of Clinical Dermatology, 2014
- Myelodysplastic syndrome hematopoietic stem cellInternational Journal of Cancer, 2012
- Zebrafish as a model for vertebrate hematopoiesisCurrent Opinion in Pharmacology, 2010
- Enzymatic and non-enzymatic sulfation mechanisms in the biological actions of minoxidilBiochemical Pharmacology, 1993